-
Laboratory Corporation of America (LH) PT Raised to $308 at Morgan Stanley
-
Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'
-
Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance
-
Labcorp to offer FDA-cleared Alzheimer's blood test nationwide by early 2026
-
Labcorp partners with Roche to implement digital pathology scanners
-
Labcorp launches first FDA-cleared blood test for Alzheimer's disease
-
Laboratory Corporation of America (LH) PT Raised to $310 at Truist
-
Laboratory Corporation of America (LH) PT Raised to $300 at Jefferies
-
Laboratory Corporation of America (LH) PT Raised to $323 at Leerink Partners
-
Laboratory Corporation of America (LH) PT Raised to $300 at Evercore ISI
-
Labcorp (LH) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY25 EPS Guidance
-
Community Health Systems to sell outreach lab assets to Labcorp for $195M
-
Privia Health adds Lance Berberian to board with tech expertise
-
Predictive Oncology (POAI) Develops Functional 3D Organoid Models Exclusively for Labcorp
-
Laboratory Corporation of America (LH) PT Raised to $283 at Morgan Stanley
-
Laboratory Corporation of America (LH) PT Raised to $274 at Mizuho
-
Labcorp (LH) Tops Q1 EPS by 6c, provides guidance
-
Labcorp (LH) Launches Molecular Residual Disease and Liquid Biopsy Solutions
-
Redburn-Atlantic Starts Laboratory Corporation of America (LH) at Buy
-
Truist Securities Reiterates Buy Rating on Laboratory Corporation of America (LH)
-
Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
-
Citi Upgrades Laboratory Corporation of America (LH) to Buy
-
Labcorp (LH) Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
-
Laboratory Corporation of America (LH) PT Raised to $285 at Truist on 'Solid Core Business Momentum'
-
Laboratory Corporation of America (LH) PT Raised to $290 at Jefferies
-
Labcorp (LH) Tops Q4 EPS by 6c ; Offers Guidance
-
Evercore ISI Upgrades Laboratory Corporation of America (LH) to Outperform
-
Labcorp (LH) Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
-
Jefferies Starts Laboratory Corporation of America (LH) at Buy
-
Laboratory Corporation of America (LH) PT Lowered to $286 at Baird
-
Labcorp (LH) CFO to Retire
-
Laboratory Corporation of America (LH) PT Raised to $268 at Leerink Partners
-
Labcorp (LH) Tops Q3 EPS by 2c, provides guidance
-
Piper Sandler Starts Laboratory Corporation of America (LH) at Neutral
-
Laboratory Corporation of America (LH) PT Raised to $265 at Jefferies
-
Laboratory Corporation of America (LH) PT Raised to $278 at Baird
-
Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae
-
Laboratory Corporation of America (LH) PT Raised to $260 at BofA Securities
-
Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx
-
Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays
-
Laboratory Corporation of America (LH) PT Raised to $261 at Baird
-
Laboratory Corporation of America (LH) PT Raised to $258 at Baird
-
Here are Oppenheimer’s best Smidcap ideas

